Pharma Stock Roundup: Regulatory Updates in Focus at PFE, BMY, RHHBY, SNY


Category: topSource: redinewsJan 18th, 2019

Pharma Stock Roundup: AZN, RHHBY Cancer Drugs, LLY, BMY New Deals in Focus


Category: topSource: redinewsDec 14th, 2018

Merck Wins Yet Again With New Keytruda Approval

Merck shares were up slightly on Wednesday after the pharma giant gave another key update for its KEYTRUDA line. The firm announced that the U.S. Food and Drug Administration (FDA) has approved........»»

Category: blogSource: 247wallstOct 31st, 2018

Defense Stock Roundup: US-Canada Trade Talk, BA"s Deal Wins, AOBC Earnings in Focus


Category: topSource: redinewsSep 3rd, 2018

Pharma Stock Roundup: JNJ & NVS" Q2 Earnings, FDA Approvals

J&J (JNJ) and Novartis (NVS) kick off earnings for pharma sector on a strong note. FDA approves J&J's latest HIV medicine and line extension of Pfizer's prostate cancer drug. .....»»

Category: personnelSource: nytJul 20th, 2018

Pharma Stock Roundup: Zoetis to Buy Abaxis, NVS Gets FDA Nod for Migraine Drug


Category: topSource: redinewsMay 19th, 2018

Gilead stock down nearly 4% as drug trial fizzles

Gilead Sciences Inc. shares fell 4% in the extended session Monday after the pharma company said a late-stage, placebo-controlled study des.....»»

Category: topSource: marketwatchFeb 11th, 2019

Dow 30 Stock Roundup: Disney Earnings Impress, Pfizer"s Cancer Drug Gets CHMP Nod


Category: topSource: redinewsFeb 8th, 2019

Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY

Pfizer (PFE), Allergan (AGN), AbbVie (ABBV) and Novartis (NVS) report Q4 results. Want the latest recommendations from Zacks Investment Research? Today, y.....»»

Category: smallbizSource: nytFeb 1st, 2019

Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY


Category: topSource: redinewsFeb 1st, 2019

Ligand Pharma stock tanks after short seller Citron calls it "pipe dream"

Shares of Ligand Pharmaceuticals Inc. fell more than 20% on Wednesday after famed short seller Andrew Left of Citron Research called the San Diego, Calif., drug compa.....»»

Category: topSource: marketwatchJan 16th, 2019

Defense Stock Roundup: Lockheed Martin, Boeing, Raytheon Score Big Wins


Category: topSource: redinewsJan 4th, 2019

Dow 30 Stock Roundup: Apple Cuts Q1 Sales View, Boeing Wins $400M Bomber Aircraft Deal


Category: topSource: redinewsJan 4th, 2019

Merck’s Blockbuster Cancer Drug Keytruda Wins Multiple Approvals in Japan

Merck shares were relatively unchanged early on Thursday after the firm announced that its blockbuster drug Keytruda reported a series of approvals in Japan......»»

Category: blogSource: 247wallstJan 3rd, 2019

Spectrum Pharma stock tanks after drug fails to get on speedier track

Shares of Spectrum Pharmaceuticals Inc. fell more than 20% in the extended session Wednesday after the company said that one of its drugs, poziotinib,.....»»

Category: topSource: marketwatchDec 19th, 2018

Big Pharma Wins Drug Approval in China Ahead of West for First Time

China has approved AstraZeneca and Fibrogen’s new anemia drug roxadustat, marking the first time a medicine from a global pharmaceutical company has received the green light there before any other market......»»

Category: asiaSource: wsjDec 19th, 2018

Telecom Stock Roundup: Qualcomm Wins Patent, Verizon"s Oath Write Off & More


Category: topSource: redinewsDec 13th, 2018

Airline Stock Roundup: UAL to Boost Latin American Base, RYAAY & DAL in Focus


Category: topSource: redinewsDec 5th, 2018

Does Keytruda"s Dominance Make Merck & Co. a Buy Now?

Can an unstoppable cancer treatment help this big pharma stock outperform for your portfolio?.....»»

Category: topSource: foxnewsDec 3rd, 2018

Tonix Pharma Rips Higher After FDA OKs Study Design For PTSD Drug

Tonix Pharmaceuticals (NASDAQ: TNXP) shares — which began to trade on a split-adjusted basis Wednesday after a decision to enact a 1-for-10 reverse stock split — were seeing strong buyin read more.....»»

Category: blogSource: benzingaNov 29th, 2018